NCT07471113Completed
Mobile App-Supported HPV and Breast Cancer Awareness Program
The Impact of a Mobile App-Supported Human Papilloma Virus and Breast Cancer Program on HPV Literacy and Breast Cancer Screening Beliefs
Source: ClinicalTrials.gov · Last updated 13 Mar 2026
Brief summary (registry, in English)
The goal of this study is to learn about the impact of a mobile application-supported education program on women's HPV literacy and their beliefs regarding breast cancer screening. The main questions it aims to answer are: * Does a mobile application-supported program increase HPV literacy levels among women? * Does this intervention strengthen women's positive beliefs and attitudes toward breast cancer screening? Researchers will examine how this holistic, health-based intervention changes participants' awareness and screening perspectives. Participants will: * Use a mobile application designed to provide education on HPV and breast cancer * Complete surveys regarding their HPV knowledge and breast cancer screening beliefs before and after the program * Engage with health-related content through the mobile platform for the duration of the study.
- Status (registry)
- Completed
- Study type
- Interventional
- Enrollment
- 70 (actual)
- First submitted
- 26 Nov 2025
- Start date
- 2 Nov 2025
- Primary completion date
- 25 Dec 2025
- Lead sponsor
- Ataturk University
- Diseases
- Cervical cancer, Childhood cancers
- NCT number
- NCT07471113
What you commit to
- Study type: Interventional
- Participants enrolled: 70
- From 2 Nov 2025 to the primary completion date, 25 Dec 2025
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- Previous diagnosis of any cancer
Other illness
- Having undergone regular breast cancer (mammography) and/or cervical cancer (Pap smear/HPV DNA test) screening within the last 3 years, in accordance with national screening guidelines
- Neurological conditions affecting cognitive function (e.g., dementia, Alzheimer's disease) or physical/psychiatric conditions that would seriously limit study participation and mobile app use
Other
- Pregnancy or breastfeeding
- Participation in another health-related research study during the study period
Who the study is looking for
- -Women aged 30-65 years
- -Literate (able to read and write)
- -Able to understand and speak Turkish
- -Able to use a smartphone
- -Willing to use the mobile application during the study period and consent to data sharing
Age in the registry: 30 months to 65 months · Sex: Female · Accepts healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Atatürk University Coordinator of this site? Confirm its status | Erzurum | Turkey (Türkiye) | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.